G.J. Dore

1.5k total citations
34 papers, 718 citations indexed

About

G.J. Dore is a scholar working on Hepatology, Epidemiology and Genetics. According to data from OpenAlex, G.J. Dore has authored 34 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hepatology, 18 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in G.J. Dore's work include Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease Diagnosis and Treatment (9 papers). G.J. Dore is often cited by papers focused on Hepatitis C virus research (30 papers), Hepatitis B Virus Studies (12 papers) and Liver Disease Diagnosis and Treatment (9 papers). G.J. Dore collaborates with scholars based in Australia, Canada and United States. G.J. Dore's co-authors include Robyn Dwyer, Kun Luo, Ingrid van Beek, J Kaldor, D Lincoln, Kathy Petoumenos, Gail Matthews, Andrew R. Lloyd, Jason Grebely and Murray Krahn and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

G.J. Dore

33 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G.J. Dore Australia	10	600	594	260	66	60	34	718
Sheila Cameron United Kingdom	13	452 0.8×	580 1.0×	155 0.6×	13 0.2×	33 0.6×	21	676
Dawn Fishbein United States	11	208 0.3×	219 0.4×	225 0.9×	137 2.1×	54 0.9×	27	424
Christine Larsen France	12	299 0.5×	320 0.5×	98 0.4×	26 0.4×	14 0.2×	25	453
Tamara McDonald United Kingdom	7	348 0.6×	547 0.9×	213 0.8×	6 0.1×	30 0.5×	8	619
L. Fonquernie France	10	99 0.2×	168 0.3×	88 0.3×	38 0.6×	40 0.7×	23	259
Victor Gabriel Switzerland	7	89 0.1×	304 0.5×	187 0.7×	25 0.4×	53 0.9×	9	428
Stanley DeVlaming Canada	7	282 0.5×	328 0.6×	145 0.6×	19 0.3×	44 0.7×	10	385
Håvard Midgard Norway	12	623 1.0×	594 1.0×	132 0.5×	6 0.1×	14 0.2×	28	689
Stephen Ko United States	11	297 0.5×	336 0.6×	106 0.4×	11 0.2×	34 0.6×	11	399
Gary Brook United Kingdom	9	337 0.6×	390 0.7×	111 0.4×	43 0.7×	30 0.5×	12	469

Countries citing papers authored by G.J. Dore

Since Specialization

Citations

This map shows the geographic impact of G.J. Dore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.J. Dore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.J. Dore more than expected).

Fields of papers citing papers by G.J. Dore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.J. Dore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.J. Dore. The network helps show where G.J. Dore may publish in the future.

Co-authorship network of co-authors of G.J. Dore

This figure shows the co-authorship network connecting the top 25 collaborators of G.J. Dore. A scholar is included among the top collaborators of G.J. Dore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.J. Dore. G.J. Dore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hajarizadeh, Behzad, Jason Grebely, Gail Matthews, Marianne Martinello, & G.J. Dore. (2017). The path towards hepatitis C elimination in Australia following universal access to interferon-free treatments. Journal of Hepatology. 66(1). S291–S292. 10 indexed citations

Grebely, Jason, F. Lamoury, Behzad Hajarizadeh, et al.. (2017). Field evaluation of Xpert ® HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples. Journal of Hepatology. 66(1). S709–S709.

Lamoury, F., Behzad Hajarizadeh, D. Martínez, et al.. (2017). Hepatitis C virus core antigen and dried blood spots as simplified hepatitis C virus diagnostic tools. Journal of Hepatology. 66(1). S710–S710. 1 indexed citations

Arduino, Jean Marie, Oren Shibolet, Alain H. Litwin, et al.. (2016). C-Edge Co-Star: Favorable Impact of Elbasvir and Grazoprevir on Health-Related Quality of Life in Treatment-Naïve HCV-Infected Persons who Inject Drugs Receiving Opioid Agonist Therapy. Journal of Hepatology. 64(2). S403–S404. 3 indexed citations

Martinello, Marianne, Kathy Petoumenos, Jason Grebely, et al.. (2016). Incidence of HCV Reinfection among Treated Individuals with Recently Acquired Infection. Journal of Hepatology. 64(2). S620–S621. 1 indexed citations

Gschwantler, Michael, G.J. Dore, M.P. Manns, et al.. (2014). Simeprevir (TMC435) with Peginterferon/Ribavirin for treatment of chronic HCV genotype 1 infection in treatment-naïve european patients in the quest-1 and quest-2 phase III trials. Zeitschrift für Gastroenterologie. 52(5). 53. 19 indexed citations

Vickerman, Peter, G.J. Dore, Jason Grebely, et al.. (2014). Who should be prioritized for HCV antiviral treatment? A cost-effectiveness analysis including individual and population prevention benefits. Queen Mary Research Online (Queen Mary University of London). 1 indexed citations

Foster, Graham R., Ira M. Jacobson, G.J. Dore, et al.. (2014). P1127 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION IN TREATMENT-NAIVE EUROPEAN PATIENTS IN THE QUEST-1 AND QUEST-2 PHASE III TRIALS. Journal of Hepatology. 60(1). S456–S456. 4 indexed citations

Aspinall, Esther, Jason Grebely, Sharon Hutchinson, et al.. (2013). 965 TRENDS IN MORTALITY AFTER DIAGNOSIS OF HEPATITIS C INFECTION – AN INTERNATIONAL COMPARISON. Journal of Hepatology. 58. S397–S398. 1 indexed citations

10.

Grebely, Jason, Gail Matthews, Andrew R. Lloyd, & G.J. Dore. (2013). Elimination of Hepatitis C Virus Infection Among People Who Inject Drugs Through Treatment as Prevention: Feasibility and Future Requirements. Clinical Infectious Diseases. 57(7). 1014–1020. 87 indexed citations

11.

Berg, Thomas, Stefan Zeuzem, Christoph P. Berg, et al.. (2013). 792 48 WEEKS OF PEGINTERFERON alfa-2a/RIBAVIRIN IMPROVES SVR24 AND DECREASES RELAPSE ACROSS HCV GENOTYPE 2/3 PATIENT SUBGROUPS NOT ACHIEVING A RAPID VIROLOGICAL RESPONSE: N-CORE STUDY. Journal of Hepatology. 58. S323–S323. 2 indexed citations

12.

Jacobson, Ira M., G.J. Dore, Graham R. Foster, et al.. (2013). 1425 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL. Journal of Hepatology. 58. S574–S574. 71 indexed citations

13.

Grebely, Jason, G.J. Dore, Maarten F. Schim van der Loeff, et al.. (2012). 894 FEMALE SEX AND VARIATIONS IN IL28B ARE INDEPENDENTLY ASSOCIATED WITH SPONTANEOUS CLEARANCE OF ACUTE HCV INFECTION. Journal of Hepatology. 56. S348–S348. 1 indexed citations

14.

Kitson, Matthew T., G.J. Dore, Peter Button, et al.. (2012). 1126 VITAMIN D STATUS IS ASSOCIATED WITH COMPLETE EVR BUT NOT SVR IN CHRONIC HEPATITIS C GENOTYPE 1 INFECTION: ANALYSIS OF THE AUSTRALASIAN CHARIOT STUDY COHORT. Journal of Hepatology. 56. S443–S444. 1 indexed citations

15.

Sievert, William, G.J. Dore, Geoffrey W. McCaughan, et al.. (2009). SIGNIFICANT HEMOGLOBIN (HB) DECLINE DURING PEGYLATED INTERFERON AND RIBAVIRIN THERAPY IN HCV GENOTYPE 1 IS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR): AN ANALYSIS FROM THE CHARIOT STUDY. Hepatology. 50(4). 1 indexed citations

16.

Matthews, Gail, Margaret Hellard, Paul Haber, et al.. (2009). Characteristics and Treatment Outcomes among HIV‐Infected Individuals in the Australian Trial in Acute Hepatitis C. Clinical Infectious Diseases. 48(5). 650–658. 84 indexed citations

17.

Thein, Hla‐Hla, Paul Maruff, Murray Krahn, et al.. (2007). Cognitive function, mood and health‐related quality of life in hepatitis C virus (HCV)‐monoinfected and HIV/HCV‐coinfected individuals commencing HCV treatment^*. HIV Medicine. 8(3). 192–202. 28 indexed citations

18.

Thein, Hla‐Hla, Paul Maruff, Murray Krahn, et al.. (2007). Improved cognitive function as a consequence of hepatitis C virus treatment^*. HIV Medicine. 8(8). 520–528. 46 indexed citations

19.

Lincoln, D, et al.. (2003). HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Medicine. 4(3). 241–249. 126 indexed citations

20.

Beek, Ingrid van, Robyn Dwyer, G.J. Dore, Kun Luo, & J Kaldor. (1998). Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ. 317(7156). 433–437. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact